crizotinib Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 1/2 (1)
Phase 2 (2)

Interventional (3)

Massachusetts General Hospital (1)
Scott R. Plotkin, MD, PhD (1)
University of Alabama at Birmingham (1)

No (3)

No (3)

Adult (18+) (3)
Pediatric (Under 18) (2)

I am/have/had

I am/have/hadcancer

I am/have/hadmeasurable disease

I am/have/hadprogressive disease

I am/have/hadmetastasis

I am/have/hadnon-small cell lung cancer

I am/have/hadros1

I am/have/hadlung cancer

I am/have/hadanaplastic lymphoma

I am/have/hadneutrophil count

I am/have/hadlymphoma

I am/have/hadmajor surgery

I am/have/hadschwartz

I am/have/hadstage iv non-small cell lung cancer

I am/have/hadtyrosine

I am/have/hadros1 gene rearrangement

I am/have/haddiscomfort

I am/have/hadmet amplification

I am/have/hadseizure

I am/have/hadtubal ligation

I am/have/hadalk gene translocation

added new label for I am/have/had

I am looking for

I am looking forcrizotinib

I am looking fortyrosine

I am looking forbinimetinib

I am looking forbrigatinib

I am looking forlacosamide

I am looking forlorlatinib

I am looking foranti-epileptic

I am looking forkinase inhibitor

I am looking forvalproic acid

I am looking forexperimental drug

I am looking forinvestigational drug

I am looking forantiepileptics

I am looking forprobe

I am looking forlevetiracetam

I am looking forcombinations

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For pediatric ages
For Seniors
Recruiting in 10s
Interventional Study
all
Genetic Disease
Recruiting

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Subjects with Neurofibromatosis Type 2 (NF2) and progressive vestibular schwannoma (VS) will be treated with crizotinib administered orally. Crizotinib will be taken continuously until disease progression or unacceptable toxicity, in continuous treatment cycles of 28 days each, for a maximum of 12 cycles.

multiple meningiomas

glioma

neurofibroma

measurable disease

cataract

0 views
16 Feb, 2024
17 locations

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Lorlatinib Combinations in Lung Cancer

This research study involves three study drugs. Lorlatinib Binimetinib Crizotinib

kinase inhibitor

ascites

lorlatinib

male sterilization

leptomeningeal disease

0 views
16 Feb, 2024
2 locations

Phase 2
For pediatric ages
For Seniors
Recruiting in 10s
Interventional Study
all
Neurology
Recruiting

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2

This is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with neurofibromatosis type 2 (NF2) with associated progressive tumors of vestibular schwannomas (VS), non-vestibular schwannomas (non-VS), meningiomas, and ependymomas. This Master Study is being conducted as a "basket" study that may allow …

multiple meningiomas

investigational therapy

glioma

experimental therapy

schwannoma

0 views
05 Aug, 2020